Experience

ICON plc

• Ireland
• Pharmaceutical Manufacturing
• 700 & Above Employee

• Senior Manager Regulatory Affairs

  • Sep 2020 - Present



Freelance

• Egypt
• Human Resources
• 1 - 100 Employee

• Regulatory Affairs Consultant

  • May 2013 - Sep 2020

  Freelance Regulatory Affairs Consultant providing consultancy services in all aspects of registration and maintenance of licences for medicinal products. With experience in mutual recognition, centralised and national licensing procedures as well as clinical trial applications. Freelance Regulatory Affairs Consultant providing consultancy services in all aspects of registration and maintenance of licences for medicinal products. With experience in mutual recognition, centralised and national licensing procedures as well as clinical trial applications.



Bayer HealthCare

• United States

• Regulatory Project Manager

  • Nov 2005 - Nov 2012

  Responsible for all aspects of registration and maintenance of licenses and clinical trial related activities for Bayer Pharma medicinal products in the Oncology, Diagnostic Imaging and Speciality Medicines portfolio

• Regulatory Affairs Manager

  • Jun 2004 - Nov 2005

  Provided consultancy services in all aspects of registration and maintenance of licenses for medicinal products on behalf of Origin clients



PharmaRegistration International

• Regulatory Affairs Consultant

  • Apr 2002 - Jun 2004

  Provided consultancy services in all aspects of registration and maintenance of licenses for medicinal products on behalf of PRI clients Provided consultancy services in all aspects of registration and maintenance of licenses for medicinal products on behalf of PRI clients



Peakdale Molecular

• United Kingdom
• Research Services

• Synthetic Organic Chemist

  • Jan 2002 - Apr 2002

  Custom design and synthesis of key chemical intermediate compounds and coordination of scale up of promising lead compounds Custom design and synthesis of key chemical intermediate compounds and coordination of scale up of promising lead compounds